phd program dkfz

Progress in Cancer Research Lectures

Dkfz international phd program.

• [email protected]

The Progress in Cancer Research (PiCR) lectures, organized by the DKFZ International PhD Program, are held by DKFZ group and division heads. Over a 3-year period the research topics of the DKFZ and the state-of-the-art in cancer research are presented. PiCR lectures take place on Thursday mornings at 9am. All lectures will be streamed via Zoom, and where possible take place in hybrid format, streamed from the DKFZ lecture hall (DKFZ Communication Center, Im Neuenheimer Feld 280). Each lecture lasts approximately 1 hour.

You will find the current program in the graphic below.

If you require a letter confirming your attendance of one or more of these lectures, please indicate this in the relevant section of the online registration form. A letter will then be emailed to you a few weeks after following the end of the current PiCR lecture module (please do not contact us to request this earlier, unless this is absolutely necessary).

For further information, please contact the DKFZ International PhD Program Office: phd-prog@ dkfz .de . 

(DKFZ PhD students: please do not register for this event via Indico, but via the DKFZ Training Portal instead.)

• Terms and conditions

• Search PhD Projects & Programmes
• PhDs by Subject
• PhDs by Institution
• Latest PhDs

German Cancer Research Center (DKFZ)

The German Cancer Research Center (DKFZ) in Heidelberg is Germany’s largest biomedical research institute. As part of the Helmholtz Association, the largest research organization in Germany, the DKFZ has an international and dynamic work environment, providing scientists with access to state-of-the-art research facilities and exceptional resources. More than 3,000 employees in over 100 divisions and research groups carry out research to unravel the causes and mechanisms of cancer development and to identify novel tools for diagnosis, treatment and prevention. With Harald zur Hausen (2008) and Stefan Hell (2014), two researchers of the DKFZ have been awarded the Nobel Prize. The DKFZ offers attractive perspectives and training opportunities for international researchers at all stages of their career.

FindAPhD. Copyright 2005-2024 All rights reserved.

Unknown    ( change )

Have you got time to answer some quick questions about PhD study?

Select your nearest city

You haven’t completed your profile yet. To get the most out of FindAPhD, finish your profile and receive these benefits:

• Monthly chance to win one of ten £10 Amazon vouchers ; winners will be notified every month.*
• The latest PhD projects delivered straight to your inbox
• Access to our £6,000 scholarship competition
• Weekly newsletter with funding opportunities, research proposal tips and much more
• Early access to our physical and virtual postgraduate study fairs

Or begin browsing FindAPhD.com

or begin browsing FindAPhD.com

*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.

Do you want hassle-free information and advice?

Create your FindAPhD account and sign up to our newsletter:

• Find out about funding opportunities and application tips
• Receive weekly advice, student stories and the latest PhD news
• Hear about our upcoming study fairs
• Save your favourite projects, track enquiries and get personalised subject updates

Create your account

Looking to list your PhD opportunities? Log in here .

THE UNOFFICIAL GUIDE FOR NEW DKFZ PHD STUDENTS - DKFZ PHD STUDENT COUNCIL, 2018-2019 - GERMAN CANCER ...

• Download HTML
• Download PDF

• Health & Fitness

• Home & Garden

• Style & Fashion

• Cars & Machinery

• IT & Technique

• Government & Politics

• Uncategorized

• Hobbies & Interests

• Interesting for you
• My settings

Cancer Research

The International PhD Program from German Cancer Research Center (DKFZ) in Heidelberg (also known as the Helmholtz International Graduate School for Cancer Research) is the interdisciplinary structured graduate school for all PhD students working at the German Cancer Research Center (DKFZ). 

German Cancer Research Center (DKFZ) in Heidelberg Multiple locations Heidelberg , Germany Not ranked Studyportals University Meta Ranking 3.0 Read 5 reviews

Our Cancer Research PhD students at German Cancer Research Center (DKFZ) in Heidelberg conduct research at the forefront of basic, computational, epidemiological and translational cancer research.

Features 

• The DKFZ is Germany’s largest biomedical research institute and has an international and dynamic work environment, providing students with access to state-of-the-art research facilities and exceptional resources. 

Programme Structure

Curriculum: 

• Cell Biology and Tumor Biology
• Functional and Structural Genomics
• Cancer Risk Factors and Prevention
• Tumor Immunology
• Imaging and Radiooncology
• Infection, Inflammation and Cancer
• Translational Cancer Research

Key information

• 36 months

Start dates & application deadlines

• Apply before 2025-05-15 00:00:00

Disciplines

Academic requirements.

We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.

English requirements

Student insurance.

Make sure to cover your health, travel, and stay while studying abroad. Even global coverages can miss important items, so make sure your student insurance ticks all the following:

• Additional medical costs (i.e. dental)
• Repatriation, if something happens to you or your family
• Home contents and baggage

We partnered with Aon to provide you with the best affordable student insurance, for a carefree experience away from home.

Starting from €0.53/day, free cancellation any time.

Remember, countries and universities may have specific insurance requirements. To learn more about how student insurance work at German Cancer Research Center (DKFZ) in Heidelberg and/or in Germany, please visit Student Insurance Portal .

Other requirements

General requirements.

• Applications are invited from students from all countries holding the equivalent of a University Diploma/Master’s degree. 
• PhD students at the DKFZ typically have a background in (molecular) biology, biochemistry, chemistry, physics, bioinformatics, computer science or epidemiology/public health studies.

Tuition Fee

International.

All PhD positions at the DKFZ are fully funded for (at least) three years. There is no tuition fee.

Living costs for Heidelberg

The living costs include the total expenses per month, covering accommodation, public transportation, utilities (electricity, internet), books and groceries.

In order for us to give you accurate scholarship information, we ask that you please confirm a few details and create an account with us.

Scholarships Information

Below you will find PhD's scholarship opportunities for Cancer Research.

Available Scholarships

You are eligible to apply for these scholarships but a selection process will still be applied by the provider.

Read more about eligibility

• missing or incomplete ?"> Missing or incomplete content
• wrong or outdated ?"> Wrong or outdated content

Other interesting programmes for you

Our partners.

Go to your profile page to get personalised recommendations!

German Cancer Research Center (DKFZ) International PhD Program

The Helmholtz International Graduate School for Cancer Research in Heidelberg is an interdisciplinary and international Ph.D. program for all students working at the German Cancer Research Center (DKFZ). Ph.D. students here conduct research at the forefront of basic, epidemiological, and translational cancer research. The curriculum is in English and includes scientific and professional training.

Duration: 3-4 years

Research areas:

•    Cell Biology and Tumor Biology •    Functional and Structural Genomics •    Cancer Risk Factors and Prevention •    Tumor Immunology •    Imaging and Radiooncology •    Infection, Inflammation, and Cancer •    Translational Cancer Research

Requirements/Qualifications:

A.    Applicants must hold or expect to have a university master’s degree, including a written master’s research thesis. B.    Degree must be in the following subjects: (molecular) biology, biochemistry, chemistry, physics, mathematics, computational biology, computer science, or epidemiology/public health studies. C.    Applicants pursuing their degree must anticipate receiving it not later than six months after the application deadline. D.    Applicant must provide a provisional certificate, or Bonafide statement from the University, stating the examination marks already obtained, should be provided. E.    Applicant must provide evidence of English Language Skills

Applications:

A.    Submit an online application B.    Applicant must provide the following information: •    Educational qualifications, honors, skills, and interests •    Statement of motivation •    2 Letters of recommendation

The next application deadline is  15 December 2023 .

Quick Overview

More from Germany: Helmholtz International Graduate School

Short term doctoral scholarships to work in usa universities.

Mathematics | Physics | Engineering & Technology | Social & Behavioral Science

United States

18 May 2022

Doctoral and Postdoctoral grants to work in USA Universities

Mathematics | Biology | Chemistry | Geography | Physics

Postdoctoral | PhD | Faculty | Research Associate

08 Jun 2023

Biomedical Sciences PhD Opportunity for International Scholars

Biology | Biomedical Sciences

01 Dec 2022

Harvard Academy Scholars program: Pre-doctoral and Postdoctoral Schola ...

Social & Behavioral Science

Postdoctoral | PhD

08 Aug 2023

Research Grants and Doctoral Programs by DAAD , Germany

Mathematics | Biology | Chemistry | Geography | History | Physics | Biotechnology | Computer Science | Organic Chemistry | Inorganic Chemistry | Physical Chemistry | Analytical Chemistry | Agricultural Sciences | Arts & Media | Economics | Journalism & Public Relation | Environment | Engineering & Technology | Social & Behavioral Science | Law

06 Jun 2023

Biology | Physics | Biomedical Sciences

10 Jul 2023

Postdoc in Chemical Biology in Pusan National University, South Korea

Chemistry | Life Sciences

Postdoctoral

09 Aug 2023

Horowitz Foundation for Social Policy Grant

03 Aug 2023

University of North Bengal, Department of Management, MBA Admission

11 Jul 2023

Postdoctoral: Department Of Space National Atmospheric Research Labora ...

Physics | Engineering & Technology | Life Sciences

Postdoctoral | Research Associate

01 Jul 2023

ERCIM Alain Bensoussan Fellowship Program: European Commission (EU)

Engineering & Technology | Life Sciences

Postdoctoral | Scientist | Research Associate

26 Jun 2023

Rajiv Gandhi Centre For Biotechnology (RGCB): PhD Program

Biology | Biotechnology | Life Sciences | Biochemistry | Bioinformatics | Molecular Biology

09 Jun 2023

Postdoc research fellow: Machine Learning and Systems Biology

Mathematics | Computer Science | Bioinformatics

15 May 2023

Doctoral Fellowship (4 Year) at the University of British Columbia (UB ...

All Disciplines

14 Mar 2023

Ph.D. Student in Material Science

Chemistry | Materials Science

31 May 2023

Ph.D. Student in Cement Environmental Chemistry at Paul Scherrer Insti ...

Chemistry | Physical Chemistry | Materials Science

Switzerland

16 May 2023

Uppsala University: 18 Postdoctoral positions

Mathematics | Chemistry | Physics | Biomedical Sciences | Social & Behavioral Science | Materials Science | Medicine | Geosciences

08 May 2023

Nanotechnology Master's and Doctoral Programs: University of Waterloo

Chemistry | Nanotechnology

PhD | Masters

24 Jul 2023

Please Sign In or Sign Up to leave a Comment.

Helpful Links

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Cancer Biol Med
• v.19(11); 2022 Nov 15

Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers

Michael baumann.

1 German Cancer Research Center (DKFZ), Heidelberg 69120, Germany

This issue of Cancer Biology & Medicine, a premium Chinese international scientific journal in this field, focuses on cooperation between Chinese and German cancer research, particularly between the Tianjin Medical University Cancer Institute & Hospital and the German Cancer Research Center (DKFZ) with its networking partners. This editorial provides a brief overview on DKFZ’s research strategy with a focus on how a national integrated cancer research and care ecosystem is evolving that benefits patients and society.

Medical need and general strategy to fight cancer through research

Although considerable progress has been made over the past few decades, cancer continues to be a major and growing health challenge worldwide. In Germany with its population of 83 million, 498,000 people are newly diagnosed with cancer every year 1 (reference year 2018, excluding non-melanoma skin cancer), and malignant diseases are the leading cause of years of life lost (YLL) in this country (accounting for 35% of YLL) 2 . Cancer incidence in Germany is expected to grow by 20% within the next decade. For Europe, current estimates suggest an increase in the annual incidence of cancer, from 4.4 million in 2020 to 5.3 million in 2040 (+21%) 3 , and globally from 19 million people today to about 30 million in 2040 (+50%). Growing and aging societies, unhealthy lifestyles, and environmental factors are the causes of the increasing cancer burden. There are enormous disparities in incidence and treatment outcome between countries and, albeit to a lesser extent, within nations. Even in the most advanced health systems, including Germany, the 5-year cancer survival rate is only about 65%. 4.65 million people in Germany are living with or after a cancer diagnosis (2017) 4 and are at risk of developing progressive disease, recurrence, or secondary cancers 1 . Many of them suffer from treatment-related morbidity, sequelae of treatment, or struggle with a reduced quality of life and disadvantages in their professional lives. These alarming global and national trends pose enormous medical, societal and economic challenges that require increased investment in cancer research and care.

Major challenges need to be tackled to reduce the burden of cancer and improve cancer treatment. Fundamental discoveries in basic research are pushing the frontiers of knowledge towards a better understanding of cancer biology or for the basis of new technologies, diagnostics or medications. To achieve substantial clinical progress, these new discoveries must be applied through translational and clinical research in three main areas ( Figure 1 ) 5 :

Strategies to decrease cancer incidence and death through research (adapted from Reference 5 ).

• Cancer prevention: up to 40% of cancer cases can be avoided by minimizing or eliminating known risk factors 6 , 7 (i.e. primary prevention). New risk factors and pathogenetic mechanisms leading to cancer need to be uncovered in order to further develop strategies counteracting the rising cancer incidence. Preventive measures offered to patients with or after cancer can reduce the risk of recurrence or unwarranted sequelae (i.e. tertiary prevention).
• Early detection: new diagnostic methods and strategies need to be developed to recognize tumors at earlier, and thus potentially curable stages (i.e. secondary prevention). Such strategies can be biomarker-based (liquid-, tissue- or breath biomarkers) or image-based; often both modalities are necessary to obtain a lab-test warning sign, which is followed-up by imaging.
• Novel and improved clinical treatments: increasingly efficient and precise diagnostics and treatments are expected to further improve cancer cure rates. In addition, new treatments have the potential to transform advanced cancers from an acutely lethal disease into a chronic, manageable disease. Novel strategies of personalized precision oncology in an integrated multidisciplinary and participatory clinical setting promise higher anti-tumor efficacy, fewer side effects and an overall better quality of life for patients.

Cancer is a uniqueIy heterogenous disease. Significant biological differences exist not only between tumor entities but equally between different patients, between different lesions of the same patient, within each individual lesion in a single patient and at different time points during disease progression and therapy. Therefore, all three broad anticancer research strategies increasingly require personalized approaches, are highly dependent on progress in data-science, and benefit from global cooperation.

Finally, once new anti-cancer strategies have been developed in clinical or basic prevention research, society needs concepts for their efficient implementation in the health system to make these innovations widely available. In addition, the benefits of such innovations need to be constantly monitored and scrutinized through health economic and outcome research.

Research at the DKFZ

The mission of the DKFZ is to make a significant contribution to decrease new cancer cases and cancer deaths – through transformative research, education of the next generation of leaders, and the transfer of results into the health system, society, and innovative products. DKFZ is primarily funded by the German Federal Ministry of Education and Research (BMBF) and the federal states in which the main center or its branches are located. DKFZ is a member of the Helmholtz Association, the largest German research organization 8 .

Currently, more than 3,000 staff members, including more than 1,300 scientists, doctoral researchers and clinician scientists, are performing basic, preclinical and clinical translational research at the DKFZ. Additionally, more than 1,500 associated or guest scientists have access to research facilities at the center in Heidelberg or at branch locations. Research covers the entire translational continuum from discovery of fundamental causes of cancer to the development of disruptive, preventive, diagnostic and therapeutic approaches, and to innovative clinical studies/trials ( Figure 2 ) 9 , 10 . The DKFZ has particular strength in areas such as stem cell research; cancer genomics; cancer prevention; tumor immunology, inflammation and infection; imaging, radiooncology and image-guided therapies. As transformative innovations often originate at the interface between different areas, DKFZ promotes an increasing number of temporary or long-term ‘horizontal’ cross topic programs including single-cell approaches, digital oncology including AI-driven approaches, or disease-specific areas such as neuro-oncology or pediatric oncology. The DKFZ Cancer Research Academy hosts the International PhD Program, one of Europe’s largest graduate programs in the biomedical field, the International Postdoc Program and the International Clinician Scientist Program as well as specialized further activities, to educate, train and mentor the next generation of leaders for tomorrow’s needs. Several advisories help the DKFZ to formulate and continuously adapt its strategy, including scientific advisory boards, a patient advisory board, and a council assembling members from industry, politics, the public sphere and communication experts.

Positioning of the DKFZ and its networks with University Medical Centers within the translational continuum (adapted from References 9 and 10 ).

Strengthening the translational research continuum by joint structures and networks

Discovery and basic cancer research at universities and academic research centers in Germany have been at the international forefront for decades. For example, the discovery of Human Papillomaviruses (HPV) as a cause of cervical cancer by 2008 Nobel laureate Harald zur Hausen in the 1970s and early 80s laid the ground for later efforts outside of Germany in vaccine development and vaccination trials that have since provided clear evidence for the prevention of this disease. Another example is the theranostic agent 177 Lu-PSMA-617 for the treatment of metastatic castrate-resistant prostate cancer, which was invented and brought into first-in-human application at the DKFZ and the University Hospital Heidelberg. However, most early phase clinical trials testing innovations of laboratories in Germany as well as the vast majority of registration trials, e.g. the VISION III study for FDA approval of 177 Lu-PSMA-617, are presently performed outside Germany 11 . Overall, the targeted translation of cutting-edge results from basic research and preclinical pipelines into early clinical trials and particularly transfer into innovative products is still a major challenge in Germany. To tackle this challenge and work towards a complete and integrated translational research and transfer continuum, the DKFZ has established institutional branches for translational and clinical cancer research together with leading university medical centers (UMCs) in Germany in recent years. These include bilateral platforms such as the Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz), and the DKFZ-Hector Cancer Institute in Mannheim as well as multi-site networks: The German Cancer Consortium (DKTK) and the National Center for Tumor Diseases (NCT) ( Figure 3 ) 9 , 10 . The emerging cooperative network is increasingly comprehensive, although there are still open areas, particularly in northern Germany. With the National Decade against Cancer (2019–2028), the BMBF has launched a unique initiative with the aim to significantly advance cancer research in Germany, to create strong and sustainable structures necessary for future challenges and to ensure that all people in Germany have access to high-quality oncological care and to innovations in cancer research – regardless of where they live.

The DKFZ and its institutional branches (adapted from References 9 and 10 ).

German Cancer Consortium (DKTK)

The DKTK was initiated by the BMBF in 2012 to provide significant contributions to bridging the gap (‘valley of death’) between basic cancer research and clinical cancer research/clinical prevention research using state-of-the-art translational and reverse translational approaches. For this, DKFZ, as the consortium’s core center, together with local university hospitals and further partners, has established translation hubs at eight sites (Berlin, Dresden, Essen/Duesseldorf, Frankfurt/Mainz, Freiburg, Heidelberg, Munich, and Tuebingen) all of which are in cancer research and care. The aim is to further develop personalized oncology approaches and to improve early detection, diagnosis and therapy of cancer. Since its inception, DKTK has implemented long-term sustained programs, innovative research platforms, and established new full professorships and junior research groups at the eight partner sites. The DKTK network trains tomorrow’s leaders in translational cancer research, with a particular focus on clinician scientists and medical scientists. In addition, DKTK has established an intramural Joint Funding Program to launch annual competitive calls for site-overarching research activities. DKTK has evolved into a powerful innovation hub that actively integrates its bridging role in the translational research continuum, and provides a platform bringing together the best cancer researchers in the country. An impressive example of success is the very prominent role played by DKTK scientists in the development of new molecular classifications for brain tumors and pediatric cancers, which have been adopted by the WHO and are now globally used in clinical practice 12 , 13 .

National Center for Tumor Diseases (NCT)

The next step within the translational research chain, namely innovative clinical translational cancer research, is still a critical bottleneck in Germany. To address this bottleneck, the NCT was founded to integrate patient-centered and translational-driven clinical cancer research with top-notch multidisciplinary cancer care. The NCT has the potential to overcome current shortcomings by creating powerful and interconnected clinical translational trial infrastructures and expertise.

In 2003, the DKFZ established a first NCT site in Heidelberg in collaboration with the University Hospital Heidelberg and the Deutsche Krebshilfe (foundation). The NCT integrates a number of central activities “under one roof” in a dedicated building, including the most important elements of multidisciplinary outpatient care and innovative clinical trial activities, particularly in the field of personalized oncology. In 2014, the BMBF decided to fund the existing NCT site in Heidelberg and a second NCT site in Dresden. These NCT sites have proved to be successful models for fostering innovative clinical cancer research, including clinical trials fueled by own preclinical pipelines. As a central element of the National Decade Against Cancer , the federal government therefore decided to expand the NCT by up to four new sites to create greater critical mass and comprehensiveness as well as to facilitate improved access to innovative clinical trials for patients nationwide. The UMCs of (i) Berlin (NCT Berlin), (ii) Cologne and Essen (NCT West), (iii) Tuebingen-Stuttgart with Ulm (NCT SouthWest), and (iv) Wuerzburg with Erlangen, Regensburg and Augsburg (NCT WERA) were selected by international peer review as candidates for the expanded NCT. They are currently working with the two existing NCTs and DKFZ on a joint strategy and implementation plan which will undergo peer-review before start of the program.

National Cancer Prevention Center (NCPC)

The NCPC, which is currently being established in a strategic partnership between the DKFZ and the Deutsche Krebshilfe , will pilot an innovative concept of personalized cancer prevention. The concept is modeled on the experience of the Comprehensive Cancer Centers, which have shown that integration of research and multidisciplinary clinical services significantly promote translation, innovation and quality of care as well as of research. Located in a new dedicated building which will be constructed at the DKFZ Heidelberg campus, the NCPC will combine biological research on mechanisms of oncogenesis and biomarkers with translational, clinical and outcome prevention and early detection research. Consultation offices and laboratories for citizens and patients seeking advice or wishing to participate in interventional prevention trials will be next door to research laboratories. Prototypic evidence-based workflows, a digital prevention unit, database and biomaterial archives, and comprehensive education programs for the next generation of prevention experts will feed into large-scale nationwide outreach initiatives.

International cooperation

The DKFZ’s strategy for internationalization aims to create synergies by teaming up with strategically selected cancer and cancer research centers of excellence around the world that ideally complement the DKFZ cancer research program. In addition to a wide spectrum or multitude of international collaborative efforts among individual scientists and within international research networks, DKFZ supports several major international partnerships at a formalized institutional level. Examples are the long-lasting bi-national DKFZ-MOST (Ministry of Science and Technology) program between scientists from the DKFZ and academic institutions in Israel, the collaboration between DKFZ and INSERM with a joint research unit in Heidelberg, the sister institution relationship with the MD Anderson Cancer Center in Houston, or joint initiatives with the US National Cancer Institute NCI, the International Agency for Research and Cancer (IARC), Cancer Research UK, Tianjin Medical University Cancer Institute & Hospital, King Hussein Cancer Center in Jordan, University and Health Ministry of Namibia, or the emerging Athens Cancer Center. DKFZ is also a key partner in leading European consortia like Cancer Core Europe and Cancer Prevention Europe. Examples for joint international efforts in education and training are a joint research school with the Weizmann Institute of Science in Israel or the International Clinician and Medical Scientist exchange program with the Princess Margaret Cancer Center in Toronto.

Perspectives

DKFZ, together with its partners at the UMCs and further institutions, works towards a coherent and high-performing cancer research landscape in Germany that spans the entire translational continuum and can effectively support excellent cancer researchers to generate impact for cancer patients and society. This long-term national investment into an integrated cancer research and care environment also serves as a powerful basis for close international partnerships to effectively fight cancer on a global scale.

Acknowledgements

Acknowledgements to Michael Brysch, (DKFZ), Philipp Gebhardt (DKFZ, DKTK), Claudia Mayer (DKFZ), Claudia Reschke (DKFZ), Maria Rius (DKFZ, NCT).

Conflict of interest statement

Michael Baumann, CEO and Scientific Chair of the German Cancer Research Center (DKFZ, Heidelberg) is responsible for collaborations with a large number of companies and institutions worldwide. In this capacity, he has signed contracts for research funding and/or collaborations, including commercial transfers, with industry and academia on behalf of his institute(s) and staff. He is a member of several supervisory boards, advisory boards and boards of trustees. Michael Baumann confirms that he has no conflict of interest with respect to this paper.

• Skip to main menu
• Skip to user menu

PHD Program Project Manager

Job Details

Reference number 2024-0147.

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

Are you interested in supporting the next generation of cancer researchers within an international and dynamic team?

The DKFZ International PhD Program offers exceptional interdisciplinary training for doctoral candidates at the German Cancer Research Center (DKFZ) and we're seeking a Project Manager to join our team.

In this role, you'll interact with internal and external PhD students and candidates, collaborate with scientists, coordinate with internal administrative departments, and engage with national and international partners. Each day presents new perspectives and interesting challenges.

Job description:

• Implementation and further development of measures to increase the international visibility of the PhD Program, including the website
• Coordination of PhD selections, including communication with candidates, DKFZ scientists and doctoral researchers, administration of the application system, organisation of the candidate reviewing process and interviews and supporting the employment processes
• Representation of the PhD Program at international career fairs and conferences
• Onboarding of new PhD students
• Application for funding at the national and European level
• Further development of PhD training activities
• Compiling reports and statistics for PhD Program activities
• Deputising for the PhD Program Manager  

Requirements:

• Doctorate in science, medicine or an equivalent degree
• Fluency in English and excellent German written and verbal communication skills
• Proven organizational capabilities and ability and enthusiasm to work independently
• Team spirit, a service-oriented approach and a sense of responsibility
• Experience in graduate education or science management and working in an international environment is advantageous
• Availability to travel internationally and flexibility to adjust working hours during peak times and for PhD events is desirable  
• Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
• Compensation according to TV-L incl. occupational pension plan and capital-forming payments
• 30 days of vacation per year
• Possibility of mobile and part-time work
• Family-friendly working environment, e.g. parent-child room and advisory services
• Sustainable travel to work: subsidized Germany job ticket
• Unleash your full potential: targeted offers for your personal development to further develop your talents
• Our Corporate Health Management Program offers a holistic approach to your well-being

Earliest Possible Start Date: 01.07.2024

Contract duration:

The position is limited to 2 years.

Dr. Lindsay Murrells Phone +49 (0)6221/42-3290

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.

Application deadline: 20. June 2024

We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome all talented applicants, regardless of their gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.

We particularly welcome applications from qualified women.

Please apply preferably via our online application tool (https://www.dkfz.de/de/stellenangebote/index.php), quoting the reference number.

We kindly ask for your understanding that we will not return documents sent by post (German Cancer Research Centre, Human Resources Department, Im Neuenheimer Feld 280, 69120 Heidelberg) and that applications by email cannot be accepted.

About the German Cancer Research Center (DKFZ)

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute and a member of the Helmholtz Association of German Research Centers . Over 3,200 staff members from 88 nations are dedicated to performing and driving cutting edge research for a life without cancer. Organized in more than 100 divisions and research groups, the focus of our 1,400 scientists is to unravel the causes and mechanisms of cancer development and progression, and to develop novel strategies for the diagnosis, early detection, prevention and treatment of cancer though innovative translational research.

Scientists at the DKFZ have received the most prestigious academic awards, including Prof. Harald zur Hausen , awarded the Nobel Prize in Physiology or Medicine in 2008 for his pioneering work on Human Papilloma Viruses (HPV),and Prof. Stefan Hell , who received the Nobel Prize in Chemistry for his research on super-resolution imaging.

The DKFZ core site is located in Heidelberg , the “ City of Science ”, which is considered one of the most beautiful cities in Germany with a highly international community: An estimated 56,000 of Heidelberg’s 160,000 inhabitants have an international background – many of whom are scientists or students.

Research Topics and Scientific Collaborations

The DKFZ is an international leader in a number of research areas including stem cell research, bioinformatics and systems biology, cancer genomics, neurooncology, pediatric oncology, cancer prevention, tumor immunology, virology, radiooncology and medical image analysis. The interdisciplinary and collaborative research environment at the DKFZ also results in excellent opportunities for computational and data scientists with interest in biomedical applications.

Research at the DKFZ is organized into six research programs :

• Cell and Tumor Biology
• Functional and Structural Genomics
• Cancer Risk Factors and Prevention
• Immunology and Cancer
• Imaging and Radiooncology
• Infection, Inflammation and Cancer

On the mission for a life without cancer, the DKFZ collaborates with renowned clinical and research institutions at the local, national and international level . A key goal is to continuously strengthen translational research activities with the aim of sustainably advancing state-of-the-art clinical cancer research in Germany and thereby improving the treatment outcomes and quality of life of cancer patients. Together with University Hospital partners across Germany, the DKFZ established the National Centers for Tumor Diseases (NCT) as leading Comprehensive Cancer Centers in Germany, as well as the Hopp Childrens’ Tumor Center (KiTZ) in Heidelberg with a specific focus on pediatric oncology. Within the German Cancer Consortium for Translational Cancer Research (DKTK) , research institutions and university hospitals at eight partner locations collaborate with the DKFZ, the core center of the DKTK, to speed up the transfer of successful cancer research into clinical practice. Furthermore, the HI-TRON in Mainz is a cooperative effort to make full use of the potential of individualized immunotherapy.

Training Programs and Career Development

Talent management and career development are central parts of DKFZ’s mission to maintain scientific excellence. The DKFZ places strong emphasis on the international recruitment and comprehensive training of excellent scientists, specifically welcoming diverse and international backgrounds.

Dedicated programs train young scientists and clinicians and prepare them for their next career step:

• DKFZ Major in Cancer Biology within the International Master Program 'Molecular Biosciences'
• DKFZ International PhD Program
• DKFZ International Postdoc Program
• DKFZ Clinician Scientist Program
• DKFZ Junior Research Groups

The DKFZ has developed programs to support the reconciliation of family and careers at all levels and international employees are supported by the International Staff Services in the planning, preparation and realization of their stay in Heidelberg.

Innovation Management

The DKFZ builds on strong Innovation Management to foster the development of innovative preventive, diagnostic and therapeutic products for maximum societal benefit. It facilitates technology transfer through licensing and support of spin-off companies. Recent examples include iOmx Therapeutics , Apogenix and mtm laboratories. The DKFZ also has strong collaborations with industry partners, such as Bayer Healthcare , Bosch , SAP and Siemens .

Share this job

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Similar jobs

Phd student (f/m/x).

• Bonn, Nordrhein-Westfalen (DE)

Postdoctoral Associate

• Houston, Texas (US)

Head of a Junior Group “Translational Immuno-Onco-Pathology”

• Munich (Landkreis), Bayern (DE)

Position:   PhD Program Project Manager

Department: DKFZ International PhD Program

Code number: 2024-0147

Are you interested in supporting the next generation of cancer researchers within an international and dynamic team?

The DKFZ International PhD Program offers exceptional interdisciplinary training for doctoral candidates at the German Cancer Research Center (DKFZ) and we're seeking a Project Manager to join our team.

In this role, you'll interact with internal and external PhD students and candidates, collaborate with scientists, coordinate with internal administrative departments, and engage with national and international partners. Each day presents new perspectives and interesting challenges.

Sie möchten in einem internationalen und dynamischen Team die nächste Generation von Forscher:innen unterstützen, die sich für ein Leben ohne Krebs einsetzen?

Das DKFZ International PhD Program bietet Promovierenden des Deutschen Krebsforschungszentrums (DKFZ) eine exzellente, interdisziplinäre Ausbildung. Wir suchen eine:n Projektmanager:in zur Verstärkung unseres Teams.

Sie werden Kontakt mit internen und externen Promovierenden, Kandidat:innen, Wissenschaftler:innen, internen Verwaltungsabteilungen sowie nationalen und internationalen Kooperationspartnern haben. Jeder Tag bringt neue Perspektiven und interessante Herausforderungen.

• Implementation and further development of measures to increase the international visibility of the PhD Program, including the website
• Coordination of PhD selections, including communication with candidates, DKFZ scientists and doctoral researchers, administration of the application system, organisation of the candidate reviewing process and interviews and supporting the employment processes
• Representation of the PhD Program at international career fairs and conferences
• Onboarding of new PhD students
• Application for funding at the national and European level
• Further development of PhD training activities
• Compiling reports and statistics for PhD Program activities
• Deputising for the PhD Program Manager  
• Umsetzung und Weiterentwicklung von Maßnahmen zur Erhöhung der internationalen Sichtbarkeit des PhD-Programms, einschließlich der Webseite
• Koordination der PhD-Auswahverfahren, einschließlich der Kommunikation mit Kandidat:innen, DKFZ-Wissenschaftler:innen und Promovierenden, Administration des Bewerbungssystems, Organisation der Interviews und Unterstützung der Einstellungsprozesse
• Repräsentation des PhD-Programms auf internationalen Karrieremessen und Konferenzen
• Onboarding von neuen Promovierenden
• Beantragung von Fördermitteln auf nationaler und europäischer Ebene
• Weiterentwicklung der Ausbildungsaktivitäten des PhD-Programms
• Erstellung von Berichten und Statistiken zu den Aktivitäten des PhD-Programms
• Vertretung der PhD-Programm-Managerin
• Doctorate in science, medicine or an equivalent degree
• Fluency in English and excellent German written and verbal communication skills
• Proven organizational capabilities and ability and enthusiasm to work independently
• Team spirit, a service-oriented approach and a sense of responsibility
• Experience in graduate education or science management and working in an international environment is advantageous
• Availability to travel internationally and flexibility to adjust working hours during peak times and for PhD events is desirable  
• Promotion in Naturwissenschaften, Medizin oder ein gleichwertiger Abschluss
• Hervorragende Englisch- und Deutschkenntnisse in Wort und Schrift
• Ausgezeichnete organisatorische Fähigkeiten und ein hohes Maß an selbständiger Arbeitsweise
• Teamgeist, serviceorientiertes Arbeiten und Verantwortungsbewusstsein
• Erfahrungen in der Promovierendenausbildung oder im Wissenschaftsmanagement und in einem internationalen Umfeld sind von Vorteil
• Bereitschaft zu internationalem Reisen und Flexibilität bei der Anpassung der Arbeitszeiten zu Spitzenzeiten und für Veranstaltungen ist wünschenswert
• Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
• Compensation according to TV-L incl. occupational pension plan and capital-forming payments
• 30 days of vacation per year
• Possibility of part-time work
• Family-friendly working environment, e.g. parent-child room and advisory services
• Sustainable travel to work: subsidized Germany job ticket
• Unleash your full potential: targeted offers for your personal development to further develop your talents
• Our Corporate Health Management Program offers a holistic approach to your well-being

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.

Earliest Possible Start Date: 01.07.2024

Duration: The position is limited to 2 years.

Application Deadline:  20.06.2024

Dr. Lindsay Murrells Phone +49 (0)6221/42-3290

Please note that we do not accept applications submitted via email.

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.

To apply for a position please use our online application portal (https://www.dkfz.de/en/stellenangebote/index.php).

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.

International PhD Program | PHD Positions in Medical Physics and Radiopharmaceutical Sciences

Position : PhD student

Institution : German Cancer Research Center (DKFZ)

Location : Heidelberg, Germany

Application closes at : Dec 15th, 2023 19:31

URL : https://www.dkfz.de/en/phd-program/index.html?campaign=phd/efomp

Are you interested in applying physical and (radio)chemical methods in cancer research?

The German Cancer Research Center (DKFZ) in Heidelberg, Germany’s largest biomedical research institute, has its own multidisciplinary research program dedicated to “Imaging and Radiooncology”. This research program is concerned with introducing new findings, methods and technologies into the diagnosis and treatment of cancer. Physicists, mathematicians, computer scientists, engineers, biologists, pharmacists and chemists strongly collaborate to tailor tumor treatment to the individual patient and to improve possibilities of local and systemic tumor control.

Main research activities are focused on:

• Development of novel approaches in diagnostics and therapy, based on physical methods
• Non-invasive imaging technologies such as CT, MRI, PET/CT, and PET/MRI
• Development of techniques for precision radiation therapy like IMRT, IGRT, MR-guided radiation therapy, proton and ion beam therapy
• Imaging Data Science
• Radiotracer and radiopharmaceutical drug development including radiochemical and radiobiological approaches to achieve efficient targeting of cancer cells
• Transfer of novel systemic diagnostic and therapeutic methods into a clinical setting for the benefit of cancer patients

More information about the groups and their research can be found here .

To apply online to the International PhD Program visit  www.dkfz.de/phd

Application deadlines

The deadline for applications is 15 May and 15 December each year.

Attachments

   DKFZ PhD Program Size: 215,97 KB

DKFZ International PhD Program 7625 views

Germany: German Cancer Research Center (DKFZ) PhD Europe , Germany May 18, 2022 Biochemistry - Bioengineering - Bioinformatics - Biology - Biomedical - Biomedical engineering - Biosciences - Biotechnology - Cancer Research - Life Sciences - Medicine and Pharma - Microbiology

The Helmholtz International Graduate School for Cancer Research in Heidelberg is the interdisciplinary and international PhD program for all students working at the German Cancer Research Center (DKFZ). PhD students here conduct research at the forefront of basic, epidemiological and translational cancer research. The curriculum is in English and includes scientific and professional training.

Duration : 3-4 years

Research areas:.

• Cell Biology and Tumor Biology
• Functional and Structural Genomics
• Cancer Risk Factors and Prevention
• Tumor Immunology
• Imaging and Radiooncology
• Infection, Inflammation and Cancer
• Translational Cancer Research

Qualifications :

• Applicants must hold or expect to hold a university master’s degree including a written master’s research thesis.
• Degree must be in the following subjects: (molecular) biology, biochemistry, chemistry, physics, mathematics, computational biology, computer science or epidemiology/public health studies.
• Applicants pursuing their degree must anticipate receiving it not later than 6 months after the application deadline.
• Applicant must provide provisional certificate or bonafide statement from the University, stating the examination marks already obtained, should be provided.
• Applicant must provide evidence English Language Skills

Applications :

• Submit online application
• Applicant must provide the following information:
• Educational qualifications, honors, skills and interests
• Statement of motivation
• 2 Letters of recommendation

The next application deadlines are: 15 December 2022.

Germany: German Cancer Research Center (DKFZ)

Related jobs, new job alert, never miss a chance.

Let us know your job expectations, so we can find you jobs better!

Funding and Awards: 200 Plus Fellowships, EMBO

Germany: European Molecular Biology Organization (EMBO) Faculty Europe , Germany May 9, 2024

FCT opens 1500 PhD Scholarship 2024

Portugal: Fundação para a Ciência e a Tecnologia (FCT) PhD Europe , Portugal April 4, 2024

Travel grants for short term visits by Boehringer Ingelheim Fonds, Germany

Grants PhD All Country , Belgium , Czech Republic , Denmark , Europe , Finland , France , Germany , Greece , Hungary , Iceland , India , Ireland , Italy , Norway , Open for all countries , Poland , Portugal , Switzerland , United Kingdom , United States March 25, 2024

PhD Fellowships: Boehringer Ingelheim Fonds, Germany

Grants PhD All Country , Austria , Belgium , Cyprus , Czech Republic , Denmark , Europe , Finland , France , Germany , Greece , Iceland , India , Italy , Norway , Portugal , Romania , Switzerland , United Kingdom March 25, 2024

FMI International PhD Program, University of Basel

Switzerland: University of Basel Scholarships PhD Europe , Switzerland March 25, 2024

PhD fellowship: Biology and Biophysics

Postdoc fellowship program: institut curie, international programs in europe: masters, phd, postdoc, research, japan foundation: individual and organization grants, sir – scholar-in-residence fulbright program, usa, 300 fellowships: adb scholarship program, japan, international postdoc korea research fellowship (krf), research grants by mcmaster university, job location.

• Europe (2,844)
• India (1,681)
• Germany (1,174)
• United Kingdom (884)
• United States (773)

Send to a friend

• { expandedNavigation=true; activeIndex=0; }"> Research landscape
• { expandedNavigation=true; activeIndex=1; }"> Your goal
• { expandedNavigation=true; activeIndex=2; }"> Plan your stay
• { expandedNavigation=true; activeIndex=3; }"> Success stories
• { expandedNavigation=true; activeIndex=4; }"> Our service
• R&D policy framework
• Research infrastructure
• Research funding system
• Universities
• Universities of applied sciences
• Technical universities
• Top universities
• Fraunhofer-Gesellschaft
• Helmholtz Association
• Leibniz Association
• Max-Planck-Gesellschaft
• Academies of sciences and humanities
• Federal institutions
• State research institutions
• What is R&D in German business?
• Why is collaboration important?
• Which sectors carry out R&D?
• Which are the leading companies?
• How do German businesses compare internationally?
• How is the start-up scene set up?
• How do I start a career?
• Good reasons
• Two ways to get your PhD
• Find your PhD position
• How to apply for a PhD
• Funding programmes
• Funding organisations
• Funding databases
• Job portals
• Career options & dual careers
• Funding & awards
• Potential employers
• Research fields
• Entry and residence
• German money-saving tips
• Cost of living
• Social insurance and health
• Bringing your family
• Information for your partner
• Support for families
• Finding a place to live
• Funding opportunities
• Recognition of professional qualifications
• Counselling
• Latest Thinking
• First-hand experiences from international researchers
• "Meet Your Future You" - series
• On-site consultation
• Our publications
• Research news
• Online talks
• Topics in focus

Cancer Research

Fraunhofer ITEM/P. Reinig

Germany is one of the leading actors in the pursuit of researching, fighting and ultimately annihilating cancer. On this page, we want to give you more information on the German research landscape in the field of cancer research and highlight some players and institutions that work towards this goal. Learn more about who does cancer research in Germany, where you can get the right funding for your work in this field and get in touch with the right people that can help you join the fight against cancer in Germany.

Who does cancer research in Germany?

Cancer research in Germany is conducted at universities and also at non-university research institutions. Almost all universities host a cancer research section. The spectrum ranges from small monothematic working groups to large interdisciplinary departments and covers a variety of topics from traditional areas to new explorative research fields. For a comprehensive overview, please take a look at our brochure “Research in Germany - Cancer Research”:

Research in Germany - Cancer Research (2022, 32 pages)

Are you interested in pursuing your PhD or getting cooperation partners in the field of Cancer Research in Germany? We invite you to explore the many opportunities available to you in Germany. This brochure provides students, early career researchers and partners from abroad with information to find places of interest and potential cooperation partners in their specific field.

On top of this, there is a lot more to discover: the  Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)  funds a multitude of individual projects in the area of cancer research. These individual grants outweigh the research consortia that are listed in the brochure both in number and in overall funding volume. The online database  GEPRIS  provides information on all DFG-funded research projects. Use this online database to find out which scientists in Germany work in your field of expertise!

Research institutions focusing on cancer research

Here are some examples of outstanding institutions and projects that focus on cancer research, both at non-university and university-based research institutions:

Deutsches Krebsforschungszentrum

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is the largest biomedical research institute in Germany and a member of the Helmholtz Association of National Research Centers. In over 90 divisions and research groups, more than 3,100 employees, of which more than 1,300 are scientists, are investigating the mechanisms of cancer, are identifying cancer risk factors and are trying to find strategies to prevent people from getting cancer. They are developing novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. (Source: www.dkfz.de )   Talent management and career development at the DKFZ plays a central role in maintaining excellence. Structured education of graduate students is provided by the DKFZ International PhD Program and, together with the DKFZ International Postdoc Program and an established Career Service, our training programs prepare junior scientists for their next career step inside or outside of academia. The new DKFZ Clinician Scientist Program fosters innovative translational research by strengthening the research profile of clinician scientists. The DKFZ offers various job and career opportunities for cancer researchers of all career levels. Current job offers can be accessed directly on dkfz.de  or here .

Contact German Cancer Research Center Im Neuenheimer Feld 280 69120 Heidelberg

Cluster of Excellence “Image-Guided and Functionally Instructed Tumor Therapies (iFIT)”

The global number of patients suffering from cancer will continue to rise in the next decades, especially due to demographic changes and an ageing population. Despite significant advancements in cancer screening and early diagnosis, around one quarter of all patients are diagnosed with advanced cancer stages, the majority of which cannot be offered a curative therapeutic option. While the number of innovative cancer therapies (molecularly targeted therapies, novel cytotoxic drugs, immunotherapies) is continuously rising, long term therapeutic success is often hampered by the development of therapy resistance.  In order to lay the foundation for the development of improved future cancer therapies, scientists of the Cluster of Excellence 2180 "Image-guided and Functionally Instructed Tumor Therapies" (iFIT) are studying fundamental tumor biological processes in solid tumors. The unique iFIT approach is based on a highly intertwined and boundless research program comprising Tübingen´s three internationally competitive research areas “Functionally Instructed Molecular Therapies”, “Immunotherapies” and “Molecular and Functional Multiparametric Imaging”.

Functionally Instructed Molecular Therapies

Scientists from this research area take advantage of advanced platforms for high throughput functional genetic screening (in particular in vivo screens) to pinpoint new vulnerabilities in therapy resistant solid tumors. A major focus also lies on screens to identify potential targets in T-cells or tumor cells, which upon inhibition via small molecules increase the therapeutic efficacy of cancer immunotherapies. Proprietary small molecule inhibitors against prioritized therapeutic targets are developed in close collaboration with the Tübingen Center for Academic Drug Discovery and Development (TüCAD2). 

Immunotherapies

How can innovative immunotherapies help to activate our defense system against tumor cells? Scientists from the research area “Immunotherapies” have performed pioneering work by elucidating the recognition mechanisms of T-cells. They recognize peptides, which are presented on special cell surface molecules. These peptides enable T-cells to detect pathological changes in the cells. Based on this, the concept of individualized cancer peptide vaccination was developed.

Molecular and Functional Multiparametric Imaging

How can multiparametric imaging be further developed to achieve a quantifiable visualization of functional, molecular and immunological mechanisms of tumors? Scientists from the research area “Molecular and Functional Multiparametric Imaging” are dedicated to develop novel-specific tracers and MR biomarkers to image immune cells in vivo as well as cellular stress and related metabolic changes of tumor cells during tumor development and after therapy.

Spokesperson and participating institutions

Spokesperson of the cluster is the oncologist Professor Lars Zender, Medical Director of the Department of Medical Oncology and Pneumology of the University Hospital Tübingen. Co-spokespersons are Professor Bernd Pichler, Director of the Werner Siemens Imaging Center at the University of Tübingen, and Professor Hans-Georg Rammensee, director of the Institute of Immunology at Tübingen University. Further participating institutions are the Max Planck Institute for Intelligent Systems , the Max Planck Institute for Biological Cybernetics , the Natural and Medical Sciences Institute at the University of Tübingen , the Margarete Fischer Bosch Institute for Clinical Pharmacology and the German Cancer Consortium .

Contact iFIT Cluster of Excellence [email protected] Röntgenweg 11 72076 Tübingen Germany  

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Fraunhofer ITEM is one of 76 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Headquartered in Hannover (Germany) and with additional facilities in Braunschweig and Regensburg, the institute aims to protect man from health hazards in our industrialized world and to contribute to the development of novel therapeutic approaches.

The Fraunhofer ITEM division in Regensburg is dedicated to  Personalized Tumor Therapy  and has a special expertise in the isolation and characterization of disseminated or circulating cancer cells. Circulating tumor cells (CTC) are isolated, for example, by taking simple blood samples (referred to as “liquid biopsy”), whereas disseminated cancer cells (DCC) can be isolated from lymph node tissue or bone marrow. These rare cells are subject to in-house, advanced next-generation multi-omics sequencing technologies and bioinformatic data analysis to reliably analyze the comprehensive genetic information at the single-cell level. Further expertise includes the analysis of cell-free, tumor-derived blood components (circulating tumor DNA, microvesicles) and innovative tissue-based analytical methods (tissue biopsy). Additionally, supported by a large clinical network, Fraunhofer ITEM in Regensburg is developing workflows for rare-cell expansion and has already established a multitude of in-vitro/in-vivo models based on DCC or CTC from various tumor entities. These preclinical models are used for high-throughput screening of substances and RNAi/CRISPR libraries to identify active agents and targets to gain a better functional understanding of DCC and CTC biology and of their response to therapy. This provides new opportunities not only for molecular diagnostics in precision oncology, but also for the investigation of pathophysiological processes in rare driver cells.

In addition, ex-vivo models developed by the institute’s Division of  Preclinical Pharmacology and Toxicology  in Hannover offer a novel opportunity to study early stages of metastasis and primary human tumors. Precision-cut tissue slice (PCTS) systems either from tumor tissue or peripheral organs co-cultured with tumor cells enable the investigation of human tissue-derived immune reactions, for instance key events of immune tolerance to tumor cells or early colonization events in metastasis. This facilitates testing of treatments such as gene therapy, checkpoint inhibitors or cell therapeutics with regard to their mode of action, targeting, efficacy and toxicity in an organotypic human setting.

The particular value of such a model is based on 1) human background, addressing the complexity of the appropriated microenvironment, 2) patient-specificity of the tumor cells in order to reflect tumor heterogeneity, 3) immune competence to assess the tolerance-inducing mechanisms, and 4) applicability of molecular and cellular manipulation and analysis tools.

Research on personalized tumor therapy is one of several key topics at Fraunhofer ITEM. Focusing on lung and inhalation, the institute’s divisions in Hannover and Braunschweig have pooled their expertise in three business units: In the business unit  Drug Development , we develop and test novel medications against respiratory diseases (including lung cancer). Scientific expertise covers manufacturing of biologics such as therapeutic antibodies, preclinical and clinical development. The business unit  Chemical Safety  is dedicated to determining the risks from potentially harmful substances. Scientific expertise includes toxicology testing, exposure assessment, analytical methods, regulatory research and risk assessment. The business unit  Translational Biomedical Engineering  offers many years of experience in the development of medical devices – specifically neural implants and medical aerosolizers – including testing and testing scenarios, safety and risk assessment. All business units offer regulatory support. Numerous test systems are available, including in-vitro, ex-vivo and in-vivo. Studies can be performed in compliance with GXP regulations.

Personalized Tumor Therapy Fraunhofer ITEM – pioneers for sustainable health

Funding for international cancer researchers in Germany

Whether you are a young international researcher looking for a scholarship, an early career researcher wanting to pursue a PhD in the field of cancer research at a German graduate school, or a more experienced researcher who wants to start a collaboration with a German partner – the right funding programme can help you with your next career step. Finding the right programme can make all the difference.

For an overview of funding opportunities, please see our brochure about funding programmes for international researchers:

Funding your research in Germany (2023-24, 80 pages)

A selection of funding programmes for German and foreign academics run by the most important research funding institutions. Target group: international students, graduates, post-docs and academics interested in a research stay in Germany.

Most of the funding programmes that are included in the brochure, are offered by the  Deutsche Forschungsgemeinschaft (DFG, German Research Foundation ), the  German Academic Exchange Service (DAAD)  and the  Alexander von Humboldt Foundation .

iStock.com/Urbazon

You can find more detailed descriptions of these organizations when looking for in-depth information on your PhD , Postdoc and Advanced Research in Germany .

Get in touch with us!

To help you navigate through the German cancer research landscape and find the right funding programme for your needs, we invite you to get in touch with us!

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): Dr. Stefan Thiel  [email protected] , Department II, Life Sciences Dr. Anke Deggerich  [email protected] , Department II, Life Sciences Ms. Bettina Schuffert [email protected] , DFG Office North America

iFIT Cluster of Excellence "Image-guided and Functionally Instructed Tumor Therapies": Ms. Eva Enzinger  [email protected]

More information:

Wir verwenden Cookies, um Ihnen ein optimales Webseiten-Erlebnis zu bieten. Dazu zählen Cookies, die für den Betrieb der Seite notwendig sind, sowie solche, die lediglich zu anonymen Statistikzwecken, für Komforteinstellungen oder zur Anzeige personalisierter Inhalte genutzt werden. Sie können selbst entscheiden, welche Kategorien Sie zulassen möchten. Bitte beachten Sie, dass auf Basis Ihrer Einstellungen womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen. Weitere Informationen finden Sie in unseren Datenschutzhinweisen .

Diese Cookies sind für die Funktionalität unserer Website erforderlich und können nicht deaktiviert werden.

Diese Cookies helfen uns zu verstehen, wie Besucher mit unserer Webseite interagieren, indem Informationen anonym gesammelt und analysiert werden. Je nach Tool werden ein oder mehrere Cookies des Anbieters gesetzt.

Inhalte von externen Medienplattformen werden standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der Zugriff auf diese Inhalte keiner manuellen Zustimmung mehr.

• Deutsche Startseite
• Englische Startseite
• Leichte Sprache
• Kontaktformualar
• Nehmen Sie Kontakt mit uns auf
• Bilder zum Download
• Anforderung der Ausschreibungsunterlagen
• Angebotsabgabe
• Vergebene Aufträge
• Chemie-Nobelpreis 2014
• Aggressiv oder kommunikativ?
• Biologische Sicherheit
• Blutgefäße und Krebs
• Brustkrebsmonat Oktober
• CareerCheck
• Corona und Krebspatienten
• Das individuelle Risiko
• Data Science @ DKFZ
• Datenartistin
• Dekade gegen Krebs
• Forschungszentrum für Bildgebung und Radioonkologie
• Heidelberger Life-Science Lab
• Hopp-Kindertumorzentrum Heidelberg KiTZ
• HPV-Impfung
• Liquid Biopsy
• Masterplan Neuenheimer Feld
• mRNA-Impfung gegen Krebs
• Patientenpartizipation
• Science in the City
• Sonnenschutz
• Tierexperimentelle Forschung am DKFZ
• Warum wir in der Krebsforschung nicht auf Tierversuche verzichten können
• Was ist Krebs?
• Weltnichtrauchertag
• Zucker und Krebs
• Unterrichtsmaterialien
• Science at DKFZ
• Distinguished Lecturer Seminar Series
• Mitarbeiter
• Publikationen
• Entzündungsstress in Stammzellen
• Experimentelle Hämatologie
• Signaltransduktion und Wachstumskontrolle
• Cancer Epigenetics
• Epitranscriptomics
• Epigenetic Clocks
• Environmental epigenetics
• Publications
• Picture Gallery
• Open Positions
• Lab Practicals
• Photo Gallery
• Press Releases
• Vaskuläre Onkologie und Metastasierung
• Klinische Neurobiologie
• Krebsstammzellen gezielt unschädlich machen
• Modellierung menschlicher Tumoren mit Hilfe von LEGO Organoiden
• Personalisierte Behandlung des Glioblastom mittels vom Patienten stammenden Organoiden
• Molekulare Prinzipien in neuralen Stammzellen, Neurogenese und Krankheiten des Zentralen Nervensystems
• Auszeichnungen und Preise
• Bildergalerie
• Stellenangebote
• Molekulare Neurobiologie
• Regulatorische Mechanismen der Genexpression
• Offene Stellen
• Fotogalerie
• Universitätsklinikum Mannheim
• Seminare mit externen Sprechern
• Malignes Melanom
• Pädiatrische Leukämie
• AG Lipid-Pathobiochemie
• Twitter und Stellenausschreibungen
• Molekulare Hämatologie - Onkologie
• Neuronale Signalwege und Morphogenese
• Wirkstoffforschung
• Engineering von Zellidentitäten und Krankheitsmodellen
• Zellmorphogenese und Signalübermittlung
• ToolsTechnologies
• Pressemeldungen
• Weitere Informationen (in Englisch)
• Cancer Metabolism | Signaling
• Computational Cancer Genomics
• Immune Modulation in Cancer
• Publikationen 2023
• Publikationen 2022
• Publikationen 2021
• Publikationen 2020
• Publikationen 2019
• Publikationen 2018
• Publikationen PubMed
• CATCH und COGNITION
• INFORM-Register
• Krebsgenomforschung
• Funktionelle Genomanalyse
• Theoretische Systembiologie
• Neuroblastom-Genomik
• Krebs- und stoffwechselassoziierte Signaltransduktion
• RNA-Protein Komplexe und Zellproliferation
• Systembiologie der Signaltransduktion
• Molekulare Grundlagen thorakaler Tumoren
• Proteomik von Stammzellen und Krebs
• Gruppen und Projekte
• TelomereConference
• TelomereHunter
• Translationale Medizinische Onkologie
• INFORM Registry
• Brain tumor classifier
• Weitere Projektförderung
• Auszeichnungen
• SARCOMABIOLOGY@DKFZ
• Publication Snapshots und Social Media
• Wegbeschreibung
• Mechanismen der genetischen Variation und Datenwissenschaft
• Forschungsschwerpunkte
• Wissenschaft
• Sektion Pädiatrische Hirntumore
• Klinische Studien
• Neuigkeiten und Veranstaltungen
• Publikationen in 2023
• Publikationen in 2022
• Publikationen in 2021
• Publikationen in 2020
• Publikationen in 2019
• Publikationen in 2018
• Ausgewählte Publikationen vor 2018
• Somatische Evolution und Früherkennung
• Translationskontrolle und Stoffwechsel
• Weichteilsarkome
• Hirngenom-Mosaizismus und Tumorgenese
• Translationale Zielmoleküle für Hirntumoren
• Genominstabilität in Tumoren
• Entwicklungsbiologische Ursprünge pädiatrischer Krebserkrankungen
• Software tools
• Translationale Medizinische Onkologie am NCT Dresden
• EPIC-Europa
• EPIC-Heidelberg
• EPIC-Spezielle Projekte
• EPIC-Ergebnisse
• EPIC-Wissenschaft
• EPIC-Kontakt
• LUSI-STUDIE
• Studienleitung und Kontakt
• Studienablauf
• Datenschutz
• Kooperationspartner
• NAKO - die Gesundheitsstudie
• PROBASE-Studie
• Hormones and Cancer
• MARIE und ihre Folgestudien
• DACHS-Studie
• REQUITE-Studie
• Biostatistischer Service und Support
• Statistikkurse
• Arbeitsgruppe Statistik in der translationalen Onkologie
• Abschlussarbeiten und Praktika
• Mitarbeitende
• Forschungspreise
• Gesundheitsökonomie
• Aktuelle Forschungsprojekte
• Aktuelle Medienberichterstattung
• Weiterführende Links
• Projekt-Team
• Fokusgruppen
• Institutionen
• DARIO Studie
• GEKKO Studie
• PROBASE Studienbeteiligte
• Tumorgenese und molekulare Krebsprävention
• Genomische Epidemiologie
• Immunoproteomik
• Personalisierte Immuntherapie
• mRNA Krebs-Immuntherapien
• Molekulare Grundlagen Gastrointestinaler Tumoren
• Infektionen und Krebs-Epidemiologie
• Forschungsschwerpunkt Infektion und Krebs
• Administration
• AG Ralf Bartenschlager
• AG Marco Binder
• AG Bruno Galy
• AG Stella Autenrieth
• AG Jürg Nüesch
• AG Stefan Seitz
• AG Barbara Leuchs
• Mikrobiom und Krebs
• Angewandte Tumorimmunität
• Antigen Presentation and T NK Cell Activation
• Gezielte Tumorvakzine
• Cell Therapy Team
• Immunogenomics Team
• Immunoimaging Team
• Immune Microenvironment Team
• Immunotherapy Brain Tumor models Team
• Immune Monitoring Team
• Offene Positionen
• Angewandte Tumorbiologie
• Erworbene Immunität und Lymphome
• Dermale Onkoimmunologie
• Krebs-Immunregulation
• Gruppenmitglieder
• Social Media
• Finanzierung
• Pädiatrische Immunonkologie
• GMP Arbeitsgruppe
• Arbeiten im Reinraum
• Prof. Dr. Eichmüller
• Aktuelle Projekte (nur in Englisch)
• Frühere Projekte
• Für Studenten
• Wissenschaftliche Projekte
• Mitarbeiter der Arbeitsgruppe
• Aktuelle Arbeit
• Was macht die IMU
• Analysemöglichkeiten
• Methoden-Portfolio
• Qualitätssicherung
• AG Computational Radiology
• AG Neuroonkologische Bildgebung
• AG Kontrastmittel
• AG 7 Tesla MRT - Neue Biomarker
• AG Forensische Bildgebung
• AG Funktionelle Bildgebung
• AG Dual- und Multienergy CT
• AG Radiomics
• AG Prostata
• LUSI-Studie
• AG Bronchialkarzinom
• AG Knochenmark
• AG Muskuloskelettale Bildgebung
• AG Mikrostrukturelle Bildgebung
• Untersuchungsablauf
• Ultraschall
• Computertomographie
• Magnetresonanztomographie
• DEGUM Ultraschallkurse
• Links zu Kooperationspartnern
• Kontakt & Anfahrt
• NMR Spektroskopie und CEST Bildgebung
• Funktionelle und Molekulare Emissionstomographie
• 7 Tesla MR: HF-Systeme und Konzepte
• 7 Tesla MR: Wasserstoffbildgebung und HF-Pulsdesign
• Diffusions-Tensor-Bildgebung
• 7 Tesla MR: Elektromagnetische Simulationen und HF-Sicherheit
• MR-geführte Therapie
• Suszeptibilitäts- und Phasenkontrastbildgebung
• 7 Tesla Multikern-MRT
• Master- und Bachelorarbeiten
• Medizin-Physik-Seminar
• Forschung (engl.)
• Mitarbeiter (engl.)
• Verbundinformationssysteme
• Mitarbeiter*innen
• Computer Basierte Patienten Modelle
• Angewandte Medizinische Strahlenphysik
• Optimierungsalgorithmen
• Medizintechnik
• Novel Detection Techniques for Ion Beams
• Physikalisch-Technische Qualitätssicherung in der Strahlentherapie
• Ionentherapie
• Neueste bildgeführte Strahlentherapie
• Klinische Forschungsgruppe
• Forschungsprojekte
• DKFZ Promotionsprogramm & offene Stellen
• Aus- und Weiterbildung
• Seminar (WiSe)
• Seminar (SoSe)
• HIRO-Ringvorlesung
• DKFZ PhD Program
• FLASH Workshop 2024
• Mitarbeiter:innen
• Intelligente Medizinische Systeme
• Morszeck Service Unit für Präklinische Studien
• RadPlanBio Plattform
• Smart Technologies für die Tumortherapie
• ETHOS am DKFZ
• LAFOV Quadra
• Klinische Projekte
• Experimentelle Projekte
• Daten- und Bildverarbeitung
• Veröffentlichungen
• Studentische Aus- und Fortbildung
• Dimitrakopoulou Strauss
• Translationale Radioonkologie
• Translationale Radiotheranostik
• Forschungsgruppen A-Z
• Nachwuchsgruppen
• Chemical Biology Core Facility
• Dieter Morszeck Biorepository
• Durchflusszytometrie
• Elektronenmikroskopie
• Zertifizierung
• Kleintierbildgebung
• Mikrobiologische Diagnostik
• Omics IT und Data Management Core Facility
• Radiopharmazeutika und Präklinische Studien
• Unsere Leistungen
• Kryokonservierung
• Test auf entzündlich regenerative Hyperplasie
• Mehrstufenkarzinogenese
• Heterografttumormodell
• Tumorerfassung
• Datenbank MITO | Models in Translational Oncology
• Lenkungsausschuss
• Weiterbildung
• Wichtige Links
• Kataloge -- Catalogues
• Elektronische Zeitschriften - Online Journal
• E-Books - ebooks
• Datenbanken - Databases
• WoS (Web of Science)
• Dokument-Lieferung - Document Delivery
• Publikationsdatenbank - Publication database
• DKFZ Archiv - DKFZ Archive
• Open Access
• Science 2.0
• Ansprechpartner - Contact
• Anschrift - Address
• Antiquariat - Second Hand
• Aufstellungssystematik - Shelf Classification
• Ausleihe - Circulation
• Benutzerhinweise - Library Use
• Beschaffungsvorschläge - Desiderata
• Fakten und Zahlen - Facts and Numbers
• Konsortien - Consortia
• Kopieren, Scannen - Copying, Scans
• Kurse, Führungen - Courses, Introductions
• DEAL - Info
• DKFZ-Intern - internal only
• Kurse und Berufsausbildung
• Core Facility Head Office - Enabling Technology Department
• INFORM im Detail
• Informationen für die teilnehmenden Kliniken (in Englisch)
• INFORM2-NivEnt im Detail
• Krebsregister Baden-Württemberg
• Management und Kontakt
• Abteilungen und Arbeitsgruppen
• Ringvorlesung

Veranstaltungen

• Heidelberger Zentrum für Personalisierte Onkologie
• Helmholtz-Gemeinschaft
• Mitglieder des Programmkomitees
• Ausschreibung
• Publikationsdatenbank
• Liste der Sprecher
• Liste der Teilnehmer
• 2009 Ein Gedi
• 2011 Kfar Giladi
• 2013 Negev Desert
• 2015 Garmisch
• 2016 Israel
• 2018 Grainau
• 2019 Israel
• Heidelberg – Israel, Science and Culture
• Publikation zum 40-jährigen Jubiläum
• Publikation zum 30-jährigen Jubiläum
• Publikation zum 20-jährigen Jubiläum
• Liste Publikationen 1976-2004
• Strategische Allianz DKFZ - Bayer HealthCare
• DKFZ PostDoc Netzwerk
• Cross Program Topic RNA@DKFZ
• Cross Program Topic epigenetics@dkfz
• WHO-Zentrum für Tabakkontrolle
• DKFZ Standort Dresden
• Health + Life Science Alliance Heidelberg Mannheim
• Arbeiten im DKFZ
• Leben in Heidelberg
• Dual Career
• Maßnahmen zur Gleichstellung
• International Staff Services
• Betriebliches Gesundheitsmanagement
• DKFZ Clinician Scientist Program
• International Postdoc Program
• Richtzenhain Doctoral Prize
• Career Service
• H3 Health Hub
• Trainee-Programm in der Administration
• Cancer Biology Students 2022
• Das DKFZ als Ausbildungsbetrieb
• Deine Benefits
• Biologielaborant (m/w/d)
• Tierpfleger (m/w/d), Forschung und Klinik
• Kaufmann (m/w/d) für Büromanagement
• Fachinformatiker (m/w/d), Anwendungsentwicklung
• Fachinformatiker (m/w/d), Systemintegration
• Bachelor of Arts, Industrie
• Bachelor of Arts, Digital Public Management (m/w/d)
• Bachelor of Science, Informatik
• Bachelor of Science, Medizinische Informatik
• Bachelor of Science, Arbeitssicherheit
• Bewerbungsprozess
• Berufsorientierungspraktikum
• Heinrich F.C. Behr-Stipendium
• K.H.-Bauer-Kurslabor
• Zahlen & Fakten
• Organigramm
• Strategische Kommunikation und Öffentlichkeitsarbeit
• Krebsrisiken - das sagt die Wissenschaft
• Bürger schützen - das tut die Politik
• Konsumenten gewinnen - das tut die Industrie
• Rauchstopp - das können Sie tun
• Das tun wir
• Ansprechpartner
• Betriebsärztlicher Dienst
• Beauftragte für Medizinproduktesicherheit
• Kompetenzen
• Strahlenschutz und Dosimetrie
• Sponsorschaft
• Sekundärnutzung von Studiendaten
• Knowledge Connector
• AG NAKO Integrationszentrum
• Grants Office
• Bundesfreiwilligendienst
• Finanzabteilung
• Informationen für Lieferanten
• Zentrale Warenannahme
• Bestellsystem e.biss
• Informationen für Dienstleister
• Infrastrukturprojekte und Raummanagement
• Innovation Management
• Rechtsabteilung
• Aktualisierungsfortbildung Projektleitersachkunde
• Patientenbeirat Krebsforschung
• Advisory Council
• Vertreterinnen
• Gründungsdokument
• Informationen zur Gleichstellung
• Gleichstellungsbeauftragte
• Gender Equality, Diversity and Inclusion Plan
• Gleichstellung und Diversität
• Familienförderung
• Work-Life Balance
• Initiativen
• News und Events
• Personalrat
• Berliner Büro
• Online-Spende
• Spendergalerie
• Spenden wegen eines Trauerfalls
• Spenden zu einem besonderen Anlass
• Spenden statt Geschenke
• Eigene Spendenaktion starten
• Unternehmensspende
• Bestellformular Erbschaftsbroschüre
• FAQ Erbschaften
• Geldauflagen
• KiTZ Stiftung im Andenken an Kirstin Diehl
• Rainer Hoenig Stiftung
• Andreas Wörner Stiftung
• Andreas Zimprich-Stiftung
• Walther und Christine Richtzenhain-Stiftung
• Life-Science Lab
• Datenschutzkonzept
• Vermietung Konferenzräumlichkeiten
• Nachhaltigkeit
• NCT Geschäftsstelle
• HI-TRON Mainz
• DKFZ-Hector Krebsinstitut
• Strategische Ausrichtung
• Krebspräventionskonzept der Deutschen Krebshilfe
• Krebspräventionsforschung am DKFZ
• Präventionsambulanz
• Cancer Prevention Graduate School
• Digitale Krebsprävention
• Was ist Übergewicht?
• Übergewicht und Krebs
• Tipps zur Risikoreduzierung
• Forderungen an die Politik
• Über die Nationale Krebspräventionswoche
• Alkohol und Krebs
• Alkoholatlas Deutschland 2022
• Quiz zum Thema Alkohol
• Mocktail Videos
• Podcast Sober Talk
• Impfung gegen Krebs
• Partner und Unterstützer
• Wissens-Update
• Wanderausstellung
• Familien-Mitmachstation
• Ernährung und Krebs
• Für Kantinen
• Für Zuhause
• Präventionsspots
• International Conference on Cancer Prevention
• Deutscher Preis für Krebspräventionsforschung
• Weiterführende Informationen und Materialien
• Information und Beratung
• Clinical Trial Office
• Patientenbeteiligung in der Krebsforschung

Nächste Veranstaltungen

Veranstaltungsreihen

Doctor of Education Leadership

Additional Information

• Download the Doctoral Viewbook
• Admissions & Aid

America needs transformative leaders in preK–12 education whose passion for education quality and equity is matched by a knowledge of learning and development, the organizational management skills to translate visionary ideas into practical success, and a firm grasp of the role of context and politics in shaping leadership. Graduates of the three-year, multidisciplinary Doctor of Education Leadership (Ed.L.D.) Program at the Harvard Graduate School of Education will be prepared to become those leaders.

The Ed.L.D Program — taught by faculty from the Harvard Graduate School of Education, the Harvard Business School, and the Harvard Kennedy School — will train you for system-level leadership positions in school systems, state and federal departments of education, and national nonprofit organizations. Ed.L.D. is a full-time, three-year program built on a cohort learning model. Cohorts consist of up to 25 students from diverse professional backgrounds (including district/charter management leaders, nonprofit directors, principals, teachers, and policy researchers) who progress through the program together.

All Ed.L.D. students receive a full tuition funding package plus stipends, work opportunities, and a paid third-year residency at a partner organization.

The Ed.L.D. Program prepares graduates to do work for the public good in the American public education sector, whether that be at the system or state level. Specifically, the program is designed to accelerate the progress graduates make toward achieving meaningful impact in influential roles and/or crossing boundaries in the following spaces in the public education sector:

• PreK–12 district or CMO leadership roles : superintendent of schools, chief academic officer, and/or deputy superintendent
• Foundation/philanthropy roles:  director, president and CEO, senior fellow
• Education nonprofit roles : president or executive director of backbone or collective impact organizations which support preK–12 schools. Ed.L.D. graduates will lead education nonprofits that explicitly focus on improving outcomes and opportunities for children, families, and communities.
• State or federal education leadership roles : commissioner or deputy commissioner roles. Could also include public education advocacy or education policy advisers to senior government officials.
• Social Entrepreneurship and Innovation roles:  Founder, CEO, president

Curriculum Information

The Ed.L.D. curriculum is a balance of multidisciplinary coursework and practice-based learning. Core courses and electives are taught by recognized leaders from across Harvard’s graduate programs in fields like data-based education reform, organizational change and innovation, and effective leadership strategies for urban schools. You will develop and test your leadership skills through team projects and an immersive third-year residency.

All students in the cohort take the same classes in four foundational content areas: learning and teaching, leadership and organizational change, politics and policy, adult development, and leadership inside and out (including one-on-one executive coaching). Courses taken during the first-year focus on practice-based learning and serve as the framework of your first-year experience.

Sample HGSE Courses

• Leading Change
• How People Learn
• Ed.L.D. Proseminar
• Leadership, Entrepreneurship, and Learning
• Race, Equity, and Leadership
• Practicing Leadership Inside and Out
• Sector Change
• The Workplace Lab for System-Level Leaders

View  all courses  in the Academic Catalog.

Each cohort member works with program advisers to choose an individualized sequence of electives from any of the Harvard graduate schools. You will work closely with the program faculty and staff during your second year to determine the best match with a partner organization for your third-year residency. Matches are driven by mutual interest between the resident and the partner organization, and each student's career and learning goals and geographic preferences.

• Second Year Practicing Leadership Inside and Out
• Driving Change 
• Education Sector Nonprofits
• Negotiation Workshop
• Coaching with Equity in Mind
• Ethnic Studies and Education
• Deeper Learning for All:  Designing a 21st Century School System
• Institutional Change in School Organizations, Systems, and Sectors

You will take part in a 10-month paid residency at one of our partner organizations. There, you will work on a strategic project which synthesizes your experience and learning into a written Capstone project. You will stay connected to your Ed.L.D. cohort and HGSE through technology and by returning to Harvard periodically for intensive workshops.

Paid Residency 

Our partner organizations include school systems and departments of education, as well as some of the nation's most influential and dynamic nonprofit, mission-based for-profit, and philanthropic organizations.

You will be intentionally pushed out of your comfort zones and asked to work systemically and make a significant contribution to the partner organization. In addition, the residency will provide you with the professional mentoring, practical experiences, and network of connections they need to position themselves as future leaders in the education sector. 

Strategic Project 

You will define (with supervisors from your partner organization) a strategic project on which to focus. You will have the opportunity to lead one or two major efforts on behalf of the organization, such as the creation or implementation of current initiatives. The project allows you to practice and improve leadership skills, add important value to the mission and strategy of the partner organization, work systemically, and hold high-level accountability.

During the residency period, you will produce a written Capstone. The Capstone is a descriptive, analytic, and reflective account of your third-year leadership contributions to a strategic project within an Ed.L.D. partner organization. It is a demonstration of your ability to engage others, develop strategy to successfully address and diagnose challenges, work toward a vision and goals, and learn from the results.

Sample Topics

• Accountability, Coherence, and Improvement: Leadership Reflection and Growth in the Los Angeles Unified School District
• Leadership Development for Entrepreneurial Education Leaders Working to Build Public & Private Sector Support
• Disrupting Teacher Preparation: Lessons in Collaboration and Innovation Across the Learning to Teach Community of Practice
• Pursuing Educational Equality for English Language Learners

Sample Summaries 

• Breaking Down Silos in a School District: Findings from an Ed.L.D. Project in Montgomery County
• Expanding Students' Access to Meaningful STEM Learning Opportunities Through Strategic Community Partnerships
• Developing a New Teacher Leadership and Compensation System in Iowa: A Consensus-Based Process
• Finding Great Teachers for Blended-Learning Schools

GSE Theses and Dissertations from Digital Access to Scholarship at Harvard (DASH)

Program Faculty

Ed.L.D. students learn with renowned faculty from the Harvard Graduate School of Education, Harvard Business School, and Harvard Kennedy School. Faculty from the three schools share their individual expertise in the Ed.L.D. Program and work collaboratively to provide a challenging and coherent experience for students. Faculty who teach in the Ed.L.D. core curriculum and advise Ed.L.D. students include:

Faculty Director

Frank D. Barnes

Frank Barnes is faculty director of the Doctor of Education Leadership Program. He has over 30 years experience as an educator, researcher, and organizer. As a chief accountability officer, he led turnaround efforts for large public school districts, including Boston Public Schools and Charlotte-Mecklenburg Schools.

Kathryn Parker Boudett

Ebony N. Bridwell-Mitchell

Jennifer Perry Cheatham

Elizabeth City

Candice Crawford-Zakian

Marshall Ganz

Adria D. Goodson

Deborah helsing.

Monica C. Higgins

Deborah Jewell-Sherman

Lisa Laskow Lahey

Mary Grassa O'Neill

Irvin Leon Scott

Catherine Snow

Michael L. Tushman

Martin west.

Introduce Yourself

Tell us about yourself so that we can tailor our communication to best fit your interests and provide you with relevant information about our programs, events, and other opportunities to connect with us.

Program Highlights

Explore examples of the Doctor of Education Leadership experience and the impact its community is making on the field:

Do We Need Happiness Teachers?

After a trip to meet with the Dalai Lama, an Ed.L.D. student says we do

Combatting Chronic Absenteeism with Family Engagement 

As post-COVID absenteeism rates continue unabated, a look at how strong family-school engagement can help

• Skip to main content
• Skip to main navigation

Graduate Programs

When you arrive at the intersection of knowledge, resources and opportunity, you have arrived at Baylor. The Hankamer School of Business offers opportunities for the seasoned business professional looking to switch industries and the recent college grad seeking to accelerate their career launch. With a variety of graduate programs to choose from, you can traverse the grounds of our main campus in Waco, congregate with other professionals in Dallas or study from the comfort of your own living room. Whether you are interested in healthcare administration, data analytics or cybersecurity, we can assist you on the journey to where you want to be.

The Master of Business Administration degree is offered in three ways: the Full-Time MBA program in Waco , the Executive MBA program in Dallas and the Online MBA program completed wherever you need to be. The MBA programs allow students to customize their degree plans to their interests, with various concentrations including Entrepreneurship and Corporate Innovation , International Trade and Supply Chain Management , and Executive Communication , just to name a few.

The Business School also offers several specialized master’s programs, including STEM-designated degrees in Business Analytics and Information Systems , Accounting degrees in Accountancy or Taxation , and a Master of Science in Economics . We also partner with the Army-Baylor Graduate Program to offer a joint Business and Health Administration degree.

The Business School also houses three doctoral programs in Entrepreneurship , Information Systems and Health Services Research . Our PhD programs help prepare future researchers, scholars and professors through rigorous and comprehensive studies.

The opportunity is now. Discover your future today.

Give to the Hankamer School of Business Graduate Programs Fund .

• Hankamer School of Business

Paul L. Foster Campus for Business and Innovation 1621 S 3rd St. Waco, TX 76706

One Bear Place #98001 Waco, TX 76798

• General Information
• Academics & Research
• Administration
• Gateways for ...
• About Baylor
• Give to Baylor
• Pro Futuris
• Social Media
• College of Arts & Sciences
• Diana R. Garland School of Social Work
• George W. Truett Theological Seminary
• Graduate School
• Honors College
• Louise Herrington School of Nursing
• Research at Baylor University
• Robbins College of Health and Human Sciences
• School of Education
• School of Engineering & Computer Science
• School of Music
• University Libraries, Museums, and the Press
• More Academics
• Compliance, Risk and Safety
• Human Resources
• Marketing and Communications
• Office of General Counsel
• Office of the President
• Office of the Provost
• Operations, Finance & Administration
• Senior Administration
• Student Life
• University Advancement
• Undergraduate Admissions
• Graduate Admissions
• Baylor Law School Admissions
• Social Work Graduate Programs
• George W. Truett Theological Seminary Admissions
• Online Graduate Professional Education
• Virtual Tour
• Visit Campus
• Alumni & Friends
• Faculty & Staff
• Prospective Faculty & Staff
• Prospective Students
• Anonymous Reporting
• Annual Fire Safety and Security Notice
• Cost of Attendance
• Digital Privacy
• Legal Disclosures
• Mental Health Resources
• Web Accessibility

An official website of the United States government

Here's how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( Lock Locked padlock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Students & recent graduates

Begin your search, pathways program.

The Pathways Program offers federal internship and employment opportunities for current students, recent graduates and those with an advanced degree. There are three different paths available.

New changes are coming soon that will expand opportunities to participants in "qualifying career or technical education programs" (which may include Registered Apprenticeship Programs, Job Corps, Climate Corps, AmeriCorps, and Peace Corps)

The Internship Program is for current students. If you're a current student in high school, college, trade school or another qualifying educational institution, you may be eligible. This program offers paid opportunities to work in federal agencies and explore federal careers while completing your education.

Learn more about the Internship Program .

The Recent Graduates Program is for those who have graduated, within the past two years, from a qualifying educational institution or certificate program. The Recent Graduates Program offers career development with training and mentorship.

You must apply within two years of getting your degree or certificate (veterans have up to six years to apply due to their military service obligation).

Learn more about the Recent Graduates Program .

• Have completed an advanced degree from a qualifying educational institution or program within the past two years of the annual application opening date.
• Expect to complete all advanced degree requirements, including the completion or successful defense of any required thesis or dissertation, by August 31 of the next year, from the opening date of the annual application announcement.

Email [email protected] for questions related to the Presidential Management Fellows Program. Questions about a specific announcement found on USAJOBS should be sent to the hiring agency using the contact information in the announcement.

Learn more about the Presidential Management Fellows Program .

Please contact [email protected] with any issues or questions related to the Pathways Programs for students and recent graduates.

Additional hiring options

• A U.S. citizen or national.
• Enrolled in or pursuing a bachelor's or graduate degree on at least a half-time basis.

Learn more about the Post-Secondary Student Hiring Authority .

This program is for those who have completed a bachelor's or graduate degree within the last two years. Veterans may have up to six years to apply. The program offers appointments to a permanent position.

Other student programs and opportunities

There are several other opportunities available to students, including:

• CyberCorps®: Scholarship for Service
• Department of Defense student opportunities
• Department of State Student Internship program
• NASA internship opportunities
• National security education programs such as Boren Scholarships and Fellowships and English for Heritage Language Speakers scholarships
• Overseas Seasonal Hire program
• Summer jobs (for example, a lifeguard)
• USAID Pathways for Students and Recent Graduates
• U.S. Department of Energy Community College Internship (CCI)
• U.S. Department of Energy Science Undergraduate Laboratory Internships (SULI)
• Virtual Student Federal Service (VSFS)

How do I know a job is open to students or recent graduates?

In the job announcement look for the This job is open to section. When a job is open to Students you'll see the Students icon: . When a job is open to Recent graduates , you'll see the Recent graduates icon: . There may be other groups listed that can also apply.

You can also select the Students or recent graduates filter. Your results will display all jobs open to students and recent graduates.

Documents you may need

Upload and submit through usajobs.

You can upload and save documents to your USAJOBS profile. Once uploaded, you can submit these forms with your job application as needed. Sign into USAJOBS or learn how to upload documents .

Additional Resources

• A-Z list of federal agencies External link. Opens in a new window.
• Federal internship FAQs
• Federal occupations by college majors
• Pathways FAQs

Other Hiring Paths

• Open to the public
• Federal employees
• Students & recent graduates
• Military spouses
• National guard and reserves
• Senior executives
• Individuals with disabilities
• Family of overseas employees
• Native Americans
• Peace Corps & AmeriCorps VISTA
• Special authorities

Undergraduate vs. Graduate: Educate Yourself On The Difference

• Undergraduate Meaning
• Undergraduate Student And Degree
• Graduate Meaning
• Graduate Degree And Student
• Graduate Origin
• Postgraduate Meaning

⚡ Quick summary

The main difference between undergraduate and graduate is that undergraduate is always used in the context of the first level of college or university education (the level where you can earn a bachelor’s degree ). In terms like graduate student and graduate degree , graduate refers to a level of advanced education beyond the undergraduate level, especially a master’s degree or doctorate . The noun graduate is more general, simply referring to a person who has completed a level of education (someone who has graduated ).

The difference between undergraduate and graduate is a difference of degrees (*throws graduation cap in the air to celebrate the pun*).

The level of education that each word involves varies depending on how the word is being used, and there are situations in which both words can be used in the same situation. For example, you can become a graduate student after graduating with an undergraduate degree.

The word graduate can mean very different things depending on whether it’s used as a noun (as in recent   high school graduates ), an adjective (as in graduate student and graduate degree ), or a verb (as in I plan to graduate next May ). The same goes for its shortened form, grad , which can be used as a noun (as in Congrats, grads! ) or an adjective (as in grad program ).

Undergraduate can also be used both as a noun (as in I’m an undergraduate at Stanford University ) or an adjective (as in I’m working toward my undergraduate degree ). It can be shortened to undergrad in both cases.

By the end of this article, you’ll have an advanced degree in all the different ways graduate, grad , undergraduate , and undergrad are used, and what they mean in each case.

What does undergraduate mean?

An undergraduate is “a student in a university or college who has not received a first, especially a bachelor’s, degree.” For example, a college student might say I’m an undergraduate at the University of Texas if they were pursuing a bachelor’s degree there.

Undergraduate is also commonly used as an adjective in this same context, in terms like undergraduate student , undergraduate degree , and undergraduate studies.

Undergraduate is often shortened to undergrad as both a noun and an adjective.

In undergraduate, the prefix under- is used to indicate a lower rank or status. The educational status of an undergraduate student is below that of a graduate student.

What’s the difference between wisdom and knowledge ? Here’s a lesson on the two terms.

What is an undergraduate student ? And what is an undergraduate degree ?

An undergraduate student is a student who is pursuing a degree at the first level of higher education (meaning the level after high school) at a college or university. Undergraduate students are typically those working to earn a bachelor’s degree (or, less commonly, an associate’s degree ). These degrees are often referred to with the general term undergraduate degree.

Outside of the US, an undergraduate degree is sometimes called a first degree. There are also other types of undergraduate degrees outside of the US, such as a foundation degree (which, like an associate’s degree, is typically a two-year degree).

What does graduate mean?

As a noun, the word graduate  [  graj -oo-it ] refers to “a person who has received a degree or diploma on completing a course of study.” In other words, a graduate is someone who has completed a particular level of schooling or an educational program—a child who just finished kindergarten and a doctor who just completed medical school are both graduates. It can even be used figuratively , as in She’s a graduate of the school of hard knocks.

As a verb, graduate [  graj -oo-eyt ] means “to receive a degree or diploma on completing a course of study.” The process of graduating—and the ceremony itself—is called graduation .

As an adjective, graduate [  graj -oo-it ] means something more specific. It’s used to indicate that a student, degree, or educational program is an advanced one, beyond the level of a bachelor’s degree. This sense of graduate is most commonly used in terms like graduate degree, graduate school , graduate program, and graduate student.

What is a graduate degree ? And what is a graduate student ?

Graduate degree typically refers to a degree beyond a bachelor’s, most commonly a master’s.

A graduate student is a student who’s pursuing an advanced degree after having earned their undergraduate degree (such as a bachelor’s degree) by graduating from an undergraduate program. Calling someone a graduate student most often means they are pursuing their master’s degree, but it may be another advanced degree, such as a PhD (You’d most commonly call such students PhD students. Or you might say they are working toward their doctorate or their doctoral degree.)

To earn a graduate degree, graduate students go to a division of a university known as graduate school , and such a program is often called a graduate program. In all of these terms, graduate is often shortened to grad : grad school , grad student , grad program . (A student doesn’t become a graduate student until they take graduate-level courses. For example, if a student graduates with a bachelor’s degree and then later pursues a different bachelor’s degree, they are still an undergraduate student .)

Some graduate studies are referred to in more specific ways: medical students go to medical school to earn their medical degree ; law students go to law school to earn their law degree.

Do you know the difference between these highly-esteemed graduate degrees and titles: PhD, MD, and Dr ?

Where does the word graduate come from?

Graduate comes from the Medieval Latin graduārī, meaning “to take a degree.” It ultimately derives from the Latin gradus, meaning “a step.” Each time you graduate, you take a step to the next level of education.

What does postgraduate mean?

The adjective postgraduate is sometimes used in the same way as the adjective sense of the word graduate, especially in the UK, as in postgraduate student or postgraduate studies.

Postgraduate should not be confused with postdoctoral , which refers to studies, research, or professional work above the level of a doctorate.

How to use undergraduate vs. graduate

The best way to sort out the different meanings of undergraduate and graduate is to determine whether each word is being used as a noun, an adjective, or a verb. Here’s an easy breakdown of the differences.

• undergraduate (noun): A college student pursuing a non-advanced degree, most commonly a bachelor’s degree. Can be shortened to undergrad.
• undergraduate (adjective): Used in the context of colleges and university programs ( undergraduate programs ) where students are pursuing a degree (generally referred to as an undergraduate degree ) that is not an advanced degree. Also sometimes shortened to undergrad.
• graduate (noun): A person who has completed a particular level of schooling or educational program. Can be shortened to grad.
• graduate (verb): To complete a level of schooling (and, typically, to receive a degree or diploma). You can graduate from kindergarten, high school, college, graduate school, medical school, etc.
• graduate (adjective): Used in the context of advanced schooling—a level beyond a bachelor’s degree, most commonly a master’s program. Used in terms like graduate student , graduate school , graduate degree , graduate program , graduate courses , etc. Often shortened to grad.

Examples of undergraduate, undergrad, graduate, and grad used in a sentence

Let’s look at some examples of these words in actual, real-life use to get the meanings straight.

• As an undergraduate, she had studied engineering; as a graduate student, she switched to architecture.
• I completed my undergraduate degree after five years and a lot of hard work.
• As a graduate student, you will be expected to complete a thesis.
• You should start thinking about graduate school applications before you graduate.
• Most of the applicants for this position are recent college graduates.
• I’m still an undergrad, but I’m hoping to start grad school next fall.
• I’m a UGA grad, but I almost went to Georgia Tech.

Go Behind The Words!

• By clicking "Sign Up", you are accepting Dictionary.com Terms & Conditions and Privacy policies.
• Name This field is for validation purposes and should be left unchanged.

No matter who is graduating, here are tips on how to craft a perfect congratulations card for their achievement.

Trending Words

Language Stories

[ mis -tr uh l ]

• Email This field is for validation purposes and should be left unchanged.

• Graduate College

Contact the NAU Office of Graduate & Professional Studies

NAU Office of Graduate & Professional Studies admission deadlines

• International students must apply on or before March 1st for fall admission, if an earlier deadline is not stipulated below.
• The deadlines listed below are subject to change, but are reviewed and updated regularly. For the most accurate deadline information, please check the NAU Office of Graduate & Professional Studies Admissions Application for the specific program.
• For full consideration of available funding (GA, tuition waivers, or scholarships) it is best to apply to the program early. Contact the program for specific funding deadlines.

Definitions:

Priority-   If a priority deadline has been specified, it is highly recommended that you submit your application on or before this date. Students that meet this deadline may be given special consideration for things such as assistantships, scholarships, fellowships, etc., if available. Rolling admission- no specific deadline has been identified. Students can apply for admission up until the start of any given term or session. Space available basis- applications will be accepted and considered if space is available in the program. Final- applications will not be accepted past this date. Admission not available- admission applications are not accepted for the specific term.

Graduate program application deadlines

Office of Graduate & Professional Studies

Mailing address, social media.